A new study questions the effectiveness of hepatitis C medications.
A medicine hailed as a ‘miracle’ drug that could eliminate hepatitis C may not actually cure the disease, a study claims.
Sick patients were offered hope with a new $40,000 direct-acting antiviral drug, which boasted it could clear the virus from the blood within 12 weeks.
The staggering price of the medicine was worth it to some because the contagious liver disease can lead to cancer and death.
Now researchers claim that although the drug may rid the blood of the virus there is no valid evidence that it completely rids the body of the infection.
|Read Full Article: Expensive hepatitis C drug does not cure virus, study says | Daily Mail Online|